Increased incidence of infection in verapamil-treated kidney transplant recipients.
Nanni
G
G
Transplant Unit, Department of Surgery, Catholic University, Roma, Italy.
Panocchia
N
N
Tacchino
R
R
Foco
M
M
Piccioni
E
E
Castagneto
M
M
D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015994:Incidence; D007239:Infections / Q000139:chemically induced*; D016030:Kidney Transplantation; D014700:Verapamil / Q000009:adverse effects* / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D014700:Verapamil